|
| 3-Nitrocinnamic acid |
|
Yersinia |
TTSS secreted effectors |
Preclinical (in vivo) |
Liang F, et al. 2003. J Biol Chem |
|
| Rosmarinic acid |
|
Aeromonas |
Biofilm |
Preclinical (in vivo) |
Rama Devi K, et al. 2016. Biofouling |
|
| (E)-N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3-phenylprop-2-enamide;hydrochloride |
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
| 1-(2,5-dimethoxyphenyl)-3-(naphthalen-1-yl)prop-2-en-1-one |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Chiaradia LD, et al. 2008. Bioorg Med Chem Lett; Mascarello A, et al. 2010. Bioorg Med Chem |
|
| 1-(2,5-dimethoxyphenyl)-3-(naphthalen-2-yl)prop-2-en-1-one |
|
Mycobacterium |
Exoenzyme |
Preclinical (in vitro) |
Chiaradia LD, et al. 2008. Bioorg Med Chem Lett; Mascarello A, et al. 2010. Bioorg Med Chem |
|
| (E)-N-(6-methylsulfonyl-1,3-benzothiazol-2-yl)-3-[3-[(2-methyl-1,3-thiazol-4-yl)methoxy]phenyl]prop-2-enamide |
|
Shigella |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Case HB, et al. 2018. Biochemistry |
|
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
